Determination of HER-2/Neu status in hepatocellular carcinoma cases

Genetic Testing

Volumn 12, Issue 2, 2008, Pages 211-214

  Bacaksiz, Aysegül ^a   Sahin, Feride Iffet ^a   Bilezikci, Banu ^a   Yilmaz, Zerrin ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; CHILD; CHROMOSOME 17; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; ONCOGENE NEU; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 17; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENES, ERBB-2; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; RECEPTOR, ERBB-2;

EID: 45549092315     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2007.0095     Document Type: Article

References (16)

1. Altimari A, Fiorentino M, Gabusi E, Gruppioni E, Conti B, D'Errico A, Grigioni WF (2002) Investigation of ErbB1 and ErbB2 expression for therapeutic targeting in primary liver tumours. Dig Liver Dis 35:332-338.
2. Anzola M (2004) Hepatocellular carcinoma: role of hepatitis B hepatitis C viruses proteins in hepatocarcinogenesis. J Viral Hepat 11:383-393.
3. Breuhahn K, Longerich T, Schirmacher P (2006) Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene 25:3787-3800.
4. Chen J-S, Lan K, Hung M-C (2003) Strategies to target HER-2/neu overexpression for cancer therapy. Drug Resist Updat 6:129-136.
5. Dandachi N, Dietze O, Hauser-Kronberger C (2002) Chromogenic in situ hybridization: a novel approach to a practical and sensitive method for the detection of HER2 oncogene in archival human breast carcinoma. Lab Invest 82:1007-1014.
6. Hamon-Benais C, Ingster O, Terris B, Couturier-Turpin M-H, Bernheim A, Feldmann G (1996) Interphase cytogenetic studies of human hepatocellular carcinomas by fluorescent in situ hybridization. Hepatology 23:429-435.
7. Hsu C, Huang C-L, Hsu H-C, Lee P-H, Wang S-J, Cheng A-L (2002) HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity. Cancer 94:415-420.
8. Huang T-J, Huang B-J, Liang Q-W, Huang C-W, Fang Y (2004) Dual fluorescence in situ hybridization in detection of HER-2 oncogene amplification in primary hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 3:62-68.
9. Ito Y, Takeda T, Sakon M, Tsujimoto M, Higashiyama S, Noda K, Miyoshi E, Monden M, Matsuura N (2001) Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma. Br J Cancer 84:1377-1383.
10. Kato A, Kuba K, Kurokawa F, Okita K, Oga A, Murakami T (1998) Numerical aberrations of chromosomes 16, 17, and 18 in hepatocellular carcinoma a FISH and FCM analysis of cases. Dig Dis Sci 431:1-7.
11. Michielsen PP, Francque SM, van Dongen JL (2005) Viral hepatitis and hepatocellular carcinoma. World J Surg Oncol 3:27.
12. Ross JS, Fletcher JA, Linette GP, Stec J, Clark E, Ayers M, Symmans WF, Pusztai L, Bloom KJ (2003) The HER-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy. Oncologist 8:307-325.
13. Sahin FI, Yilmaz Z, Yagmurdur MC, Ataç FB, Ozdemir BH, Karakayali H, Demirhan B, Haberal M (2006) Clinical findings and HER-2/neu gene amplification status of breast carcinoma patients. Pathol Oncol Res 12:211-215.
14. Tibiletti MG (2004) Specificity of interphase fluorescence in situ hybridization for detection of chromosome aberrations in tumor pathology. Cancer Genet Cytogenet 155:143-148.
15. Xian Z-H, Zhang S-H, Cong W-M, Wu W-Q (2005) Overexpression/amplification of HER-2/neu is uncommon in hepatocellular carcinoma. J Clin Pathol 58:500-503.
16. Yilmaz Z, Sahin FI, Atalay B, Ozen O, Caner H, Bavbek M, Demirhan B, Altinors N (2005) Chromosome 1p36 and 22qter deletions in paraffin block sections of intracranial meningiomas. Pathol Oncol Res 11:224-228.